Development Of A High Performance Covid-19 Immunoassay, An Essential Tool To Establish Immunity Passports In The Luxembourgish Population (COV-Immun)

  • Funded by Luxembourg National Research Fund
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $54,000
  • Funder

    Luxembourg National Research Fund
  • Principal Investigator

    Christiane Hilger
  • Research Location

    Luxembourg
  • Lead Research Institution

    Luxembourg Institute of Health (LIH)
  • Research Priority Alignment

    N/A
  • Research Category

    Pathogen: natural history, transmission and diagnostics

  • Research Subcategory

    Diagnostics

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The current situation of lock-down in many countries creates a strong need for large screening efforts in order to assess the immune status of the population and to advice decision makers on measures to relaunch social and economic activites. Due to the critical need for serological testing on high numbers of individuals over several months, shortages are predictable and a major threat to society. The present proposal aims at the setup of a high-performance and flexible diagnostic assay using an immunodetection technique and recombinant viral surface proteins expressed and purified in Luxembourg, which can be readily adapted to changing needs, such as the inclusion of newly emerging specific virus strains in routine testing or the targeted monitoring of immune response kinetics in clinical studies.